| Evolution of the average Target Price on NOVAVAX, INC. |
|
|
|
| Target Price consensus revisions : last 18 months |
|
|
|
| Recommendations (Chart) NOVAVAX, INC. |
|
|
|
| Analyst Recommendations on NOVAVAX, INC. |
|
| 08/10 | ANALYST RECOMMENDATIONS : Berkshire Hathaway, eBay, General Electric, HSBC, Novavax... | |
| 08/09 | NOVAVAX : B. Riley Raises Novavax's PT to $305 from $286, Notes Potential to Supply Higher-than-Proj.. | MT |
| 06/15 | NOVAVAX : Cantor Fitzgerald Adjusts Novavax PT to $272 From $217, Maintains Overweight Rating | MT |
| 05/12 | NOVAVAX : B. Riley Lowers Novavax' Price Target to $286 from $365, Notes Weakening Competitive Posit.. | MT |
| 05/12 | NOVAVAX : Cantor Fitzgerald Adjusts Price Target on Novavax to $217 From $338, Maintains Overweight .. | MT |
| 05/12 | NOVAVAX : HC Wainwright Adjusts Price Target on Novavax to $294 From $317, Maintains Buy Rating | MT |
| 05/12 | NOVAVAX : JPMorgan Cuts Novavax to Neutral From Overweight, Price Target to $161 From $285 | MT |
| |
|
|
|
|
Novavax tumbles after report on COVID-19 vaccine production delay |
|
| Mean consensus |
OUTPERFORM |
| Number of Analysts |
6 |
| Last Close Price |
193,96 $ |
| Average target price |
260,60 $ |
| Spread / Average Target |
34,4% |
| High Price Target |
305,00 $ |
| Spread / Highest target |
57,2% |
| Low Price Target |
172,00 $ |
| Spread / Lowest Target |
-11,3% |
Consensus revision (last 18 months)
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
